APM gathers more than 20 key players from public and private sectors: Bioaster, Biocodex, Biofortis Mérieux NutriSciences, Biose Industrie, Cynbiose, Cynbiome, Eligo Bioscience, EverImmune, GMT, INRAE, INSERM, Lallemand, Luxia, LyonBiopôle, MaaT Pharma, Medicen, Microbiome Fundation, Nexbiome, Novobiome, Seventure Partners, Stellate Therapeutics, Skyepharma, TargEDys et Ysopia Bioscience. Leading the way in Europe to bring microbiome-based innovations to market. Created in 2022, Alliance Promotion Microbiote is an independent, non-profit organization. Our goal is to position France as the European leader in the development, production, and commercialization of therapeutic microbiome-based innovations. APM gathers more than 20 key players from public and private sectors. From bench to bedside, APM encompasses the entire value chain of the microbiome industry. We work to accelerate the translation of basic research towards market launch of microbiome-based innovations, to meet important medical needs and improve the quality-of-life of millions of patients.